Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Effects of valsartan on morbidity and mortality in heart failure patients not receiving ACE inhibitors — Aldo Maggioni (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Effects of valsartan on morbidity and mortality in heart failure patients not receiving ACE inhibitors
Shared by
Aldo Maggioni
Effects of valsartan on morbidity and mortality in heart failure patients not receiving ACE inhibitors
Article
2002
en
Authors
+3 more
Aldo Maggioni
IA
Inder S. Anand
SG
Sidney O. Gottlieb
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
Aldo Maggioni
,
Inder S. Anand
,
Sidney O. Gottlieb
,
Roberto Latini
,
Gianni Tognoni
,
Jay N. Cohn
Letter
2020
Heart failure features and sacubitril/valsartan effects
Gabriella Malfatto
,
Alessandra Villani
,
Gianfranco Parati
Article
2003
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
Inder S. Anand
,
Lloyd D. Fisher
,
YannTong Chiang
,
Roberto Latini
,
Serge Masson
,
Aldo Maggioni
,
Robert Glazer
,
Gianni Tognoni
,
Jay N. Cohn
Article
2004
Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT
Henry Krum
,
Peter E. Carson
,
Csaba Farsang
,
Aldo Maggioni
,
Robert Glazer
,
Nora Aknay
,
YannTong Chiang
,
Jay N. Cohn
Article
2006
Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
Peter P. Liu
,
Aldo Maggioni
,
Eric J. Velazquez
Discussion(0)
No comments yet. Be the first to comment.